Case Reports
Clozapine-induced neuroleptic malignant syndrome
Affiliations
- PMID: 2005072
Item in Clipboard
Case Reports
Clozapine-induced neuroleptic malignant syndrome
J Clin Psychiatry.
1991 Mar.
Abstract
Neuroleptic malignant syndrome (NMS), a rare but serious side effect of psychotropic drugs, is usually attributed to blockade of striatal and hypothalamic dopaminergic tracts. Clozapine is an atypical antipsychotic that has minimal extrapyramidal effects and might not be expected to cause NMS. The authors report the development of NMS in a 30-year-old white man after three 25-mg clozapine doses. To their knowledge, this is the first case of NMS linked with clozapine in which concurrent psychotropic medications cannot be implicated.
Comment in
-
NMS and lethal catatonia.J Clin Psychiatry. 1992 Aug;53(8):294-5. J Clin Psychiatry. 1992. PMID: 1500409 No abstract available.
Similar articles
-
Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369. World J Biol Psychiatry. 2009. PMID: 19673089
-
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Encephale. 2008. PMID: 19081460 Review. French.
-
[Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].Fortschr Neurol Psychiatr. 1993 Jun;61(6):217-22. doi: 10.1055/s-2007-999090. Fortschr Neurol Psychiatr. 1993. PMID: 8330832 Review. German.
-
Neuroleptic malignant syndrome associated with clozapine use.J Clin Psychiatry. 1991 Mar;52(3):102-4. J Clin Psychiatry. 1991. PMID: 2005071
-
A case of clozapine-induced neuroleptic malignant syndrome.J Clin Psychiatry. 1991 Mar;52(3):99-101. J Clin Psychiatry. 1991. PMID: 1672311
Cited by
-
Adverse effects of antipsychotic drugs.Drug Saf. 1993 Dec;9(6):429-36. doi: 10.2165/00002018-199309060-00005. Drug Saf. 1993. PMID: 7907481 Review.
-
Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.CNS Drugs. 2009;23(6):477-92. doi: 10.2165/00023210-200923060-00003. CNS Drugs. 2009. PMID: 19480467 Review.
-
Clinical profile of clozapine: adverse reactions and agranulocytosis.Psychiatr Q. 1992 Spring;63(1):51-70. doi: 10.1007/BF01064682. Psychiatr Q. 1992. PMID: 1438605 Review.
-
When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.Schizophr Res. 2012 Feb;134(2-3):180-6. doi: 10.1016/j.schres.2011.10.014. Epub 2011 Nov 22. Schizophr Res. 2012. PMID: 22113154 Free PMC article.
-
Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis.Case Rep Med. 2015;2015:703218. doi: 10.1155/2015/703218. Epub 2015 Feb 10. Case Rep Med. 2015. PMID: 25755670 Free PMC article.